Pharco Pharmaceuticals

Pharco Pharmaceuticals is the founder of the corporation and is the second private Egyptian shareholding pharmaceutical company established in 1984. It started production in 1987 formulating, producing and marketing about 450 brands, generics, branded generics and licensed products to date.

Pharco Pharmaceuticals started with the manufacturing of antibiotics under license from Mead Johnson (now known as Bristol-Myers Squibb) and soft gelatin capsules (using RP Scherer technology), in addition to other traditional pharmaceutical forms. These products cover most of the pharmacological groups and all the conventional pharmaceutical dosage forms. Pharco Pharmaceuticals has a separate dedicated facility for manufacturing of sterile and non-sterile Penicillin.

Pharco Pharmaceuticals has scientific offices; KSA, Yemen, UAE, Bahrain, Lebanon, Libya and Romania and exports to 50+ countries. Throughout the years Pharco Pharmaceuticals has created several brands which have become market leaders in both local and international markets; Gratisovir 400mg, Rani effervescent, Fawar Fruit, Ciprofar 500 MG tablets, Spasmo Digestin, Delcophen amp, Royal jelly, Uricol effervescent, Urinex caps, Bilichol caps, Mirazid and Baby Drink. Currently a major cardiovascular line is up to date.

Pharco Pharmaceuticals is located and head quartered in Amriya, Alexandria, Egypt.

EUROPEAN EGYPTIAN PHARMACEUTICALS

European Egyptian Pharmaceutical Industry is the first pharmaceutical company in Africa to be prequalified from the World Health Organization (WHO). European Egyptian Pharmaceutical Industries (EEPI) is a private Egyptian shareholding pharmaceutical company based in Alexandria, Egypt. It was founded in 1998 and started production in 2002. EEPI was established with the aim to export to the regulated markets. EEPI is certified by the European Union authorities (part of the PIC/S scheme). EEPI markets, distributes, and exports our products globally by fostering a strong network of partnerships. EEPI products have significantly increased annually in the Egyptian market. Top products; Gratiziano 400mg, Toplixil, ketofan, Ciprofloxancin 500 mg Gastrozale, nevrovit tabs. (EEPI) was acquired by Pharco Corporation in 2002 and is located in Amriya, Alexandria, Egypt.